Assertio Therapeutics (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Assertio Therapeutics" in English language version.

refsWebsite

Global rank English rank

6reuters.com

49^th place

47^th place

3web.archive.org

1^st place

2google.com

163^rd place

185^th place

2bizjournals.com

407^th place

241^st place

2pharmacytimes.com

low place

2prnewswire.com

406^th place

258^th place

2fiercepharma.com

low place

8,921^st place

2chicagobusiness.com

4,398^th place

2,433^rd place

2depomedinc.com

low place

1bloomberg.com

99^th place

77^th place

1yahoo.com

38^th place

40^th place

1cnbc.com

220^th place

155^th place

1assertiotx.com

low place

1doi.org

2^nd place

1nih.gov

4^th place

1semanticscholar.org

11^th place

8^th place

1businesswire.com

615^th place

407^th place

1biospace.com

low place

7,595^th place

1forbes.com

54^th place

48^th place

1cbsnews.com

108^th place

80^th place

1fiercebiotech.com

low place

8,828^th place

1nytimes.com

7^th place

1beckershospitalreview.com

low place

9,902^nd place

1archive.today

14^th place

1iwpharmacy.com

low place

1globenewswire.com

2,614^th place

1,549^th place

1westfaironline.com

low place

1bloomberglaw.com

5,670^th place

3,086^th place

archive.today

"Depomed Announces US Food and Drug Administration Approval of GRALISE(TM) (gabapentin) Once-Daily Tablets for Treatment of Post-Herpetic Neuralgia" (Press release). Depomed. Jan 28, 2011. Archived from the original on February 5, 2014. Retrieved Feb 5, 2014.

assertiotx.com

Marketed Products, Assertio, 2019, retrieved November 25, 2019

beckershospitalreview.com

Anderson, Maia (November 20, 2019), 31 drugmakers at high risk for bankruptcy in 2020, Beckers Hospital Review, retrieved November 20, 2019

biospace.com

Depomed, Inc. Reports 2005 Year End Financial Results, BioSpace / Business Wire, March 14, 2006, retrieved November 25, 2019

bizjournals.com

Levine, Daniel S. (September 26, 2004), Drugmaker Depomed takes shot at billions, San Francisco Business Times, retrieved November 25, 2019
Leuty, Ron (October 21, 2013), PDL grabs royalties, Depomed gets cash in diabetes drug deal, San Francisco Business Times, retrieved November 25, 2019

bloomberg.com

Assertio Therapeutics Inc, Bloomberg, retrieved November 20, 2019

bloomberglaw.com

news.bloomberglaw.com

Insurers Seek to Avoid Being Drawn Into Opioid Litigation, Bloomberg, January 17, 2019, retrieved November 20, 2019

businesswire.com

Depomed Reports 2003 Year End Financial Results, DepoMed, March 3, 2004, retrieved November 25, 2019

cbsnews.com

Edwards, Jim (November 3, 2010), "How the Humble Wooden Pallet Paralyzed Big Pharma and Now Faces Extinction", CBS News, retrieved November 25, 2019

chicagobusiness.com

Liu, Evonne (March 20, 2018), Lake Forest pharma complex attracts another HQ, Crain's Chicago Business, retrieved November 25, 2019
Goldberg, Stephanie (September 6, 2019), Opioid habit hangs on at Lake Forest drugmaker, Crain's Chicago Business, retrieved November 20, 2019

cnbc.com

Globe Newswire, CNBC, August 15, 2018, archived from the original on January 21, 2019, retrieved November 20, 2019

depomedinc.com

investor.depomedinc.com

Results in 2015, depomedinc.co, 2015, retrieved November 20, 2019^{[dead link‍]}
"Depomed Announces US Food and Drug Administration Approval of GRALISE(TM) (gabapentin) Once-Daily Tablets for Treatment of Post-Herpetic Neuralgia" (Press release). Depomed. Jan 28, 2011. Archived from the original on February 5, 2014. Retrieved Feb 5, 2014.

doi.org

"Gabapentin Extended-Release - Depomed: Gabapentin ER, Gabapentin Gastric Retention, Gabapentin GR.", Drugs in R&D, 8 (5), Drugs R. D.: 317–20, 2007, doi:10.2165/00126839-200708050-00005, PMID 17767396, S2CID 195340176

fiercebiotech.com

Depomed Licenses Acuform(R) Technology and Glumetza(R) Data to Boehringer Ingelheim, Fierce Biotech, March 16, 2011, retrieved November 25, 2019^{[permanent dead link‍]}

fiercepharma.com

"Troubled Depomed sells off Nucynta, axes 40% of workforce to pare down costs". FiercePharma. Retrieved 2019-10-15.
Helfand, Carly (August 15, 2018), Depomed joins ranks of scandal-plagued pharmas rehabbing their reputations with a name change, FiercePharma, retrieved November 20, 2019

forbes.com

Kam, Ken (May 21, 2010), "Special Delivery From Depomed", Forbes, retrieved November 25, 2019

globenewswire.com

"Depomed Files Patent Infringement Lawsuit Against Gralise(R) ANDA Filers" (Press release). Depomed. Mar 5, 2012. Retrieved Jan 2, 2016 – via Globe Newswire (NASDAQ).

google.com

"DEPO Income Statement". Yahoo Finance. Retrieved 16 January 2017.
"Depomed Inc: NASDAQ:DEPO quotes & news". Google Finance. Archived from the original on December 20, 2013. Retrieved Jan 29, 2014.

iwpharmacy.com

RPh, Meaghan Byrne, PharmD , CPE & Frank Pallaria. "Dealing with Prescription Drug Shortages". www.iwpharmacy.com. Retrieved 2019-10-15.{{cite web}}: CS1 maint: multiple names: authors list (link)

nih.gov

pubmed.ncbi.nlm.nih.gov

"Gabapentin Extended-Release - Depomed: Gabapentin ER, Gabapentin Gastric Retention, Gabapentin GR.", Drugs in R&D, 8 (5), Drugs R. D.: 317–20, 2007, doi:10.2165/00126839-200708050-00005, PMID 17767396, S2CID 195340176

nytimes.com

J. de la Merced, Michael (April 28, 2016), "Starboard Value's Rise to Activist Prominence", The New York Times, retrieved November 20, 2019

pharmacytimes.com

Holmberg, Monica (April 1, 2006), Depomed and Esprit Pharma's Proquin XR, Pharmacy Times, retrieved November 25, 2019
Holmberg, Monica (January 9, 2012), New FDA Actions: Depomed Inc's Gralise, January 2012 Aging Population, vol. 78, Pharmacy Times, retrieved November 25, 2019

prnewswire.com

Depomed Announces Acquisition Of Zipsor® (diclofenac potassium) From Xanodyne Pharmaceuticals, Inc., Depomed, June 21, 2012, retrieved November 25, 2019
"Depomed Announces Acquisition Of Zipsor® (diclofenac potassium) From Xanodyne Pharmaceuticals, Inc" (Press release). Depomed. Jun 21, 2012. Retrieved Feb 5, 2014 – via PRNewswire.

reuters.com

Heavey, Susan (July 8, 2008), Antibiotics can harm tendons, FDA warns, Reuters, retrieved November 25, 2019
Nathan, Vidya L. (July 7, 2015), Horizon Pharma goes hostile with $3 billion offer for Depomed, Reuters, retrieved November 20, 2019
Roumeliotis, Greg (September 15, 2016), Exclusive: Drugmaker Depomed prepares to explore a sale - sources, Reuters, retrieved November 20, 2019
Herbst-Bayliss, Svea (March 29, 2019), Starboard abandons campaign to scuttle Bristol-Myers-Celgene deal, retrieved November 25, 2019
"Depomed Inc (DEPO.O) Company Profile". Reuters. Archived from the original on October 22, 2008. Retrieved Feb 5, 2014.
Raymond, Nate (March 19, 2019), Assertio Therapeutics beats investor lawsuit over opioid marketing, Reuters, retrieved November 20, 2019

semanticscholar.org

api.semanticscholar.org

"Gabapentin Extended-Release - Depomed: Gabapentin ER, Gabapentin Gastric Retention, Gabapentin GR.", Drugs in R&D, 8 (5), Drugs R. D.: 317–20, 2007, doi:10.2165/00126839-200708050-00005, PMID 17767396, S2CID 195340176

web.archive.org

"Depomed Inc: NASDAQ:DEPO quotes & news". Google Finance. Archived from the original on December 20, 2013. Retrieved Jan 29, 2014.
Globe Newswire, CNBC, August 15, 2018, archived from the original on January 21, 2019, retrieved November 20, 2019
"Depomed Inc (DEPO.O) Company Profile". Reuters. Archived from the original on October 22, 2008. Retrieved Feb 5, 2014.

westfaironline.com

Zimmerman, Kevin (August 30, 2018), Purdue Pharma settles patent infringement suit over OxyContin for $62M, retrieved November 20, 2019

yahoo.com

finance.yahoo.com

"DEPO Profile | Depomed, Inc. Stock". Yahoo! Finance. Retrieved Jan 2, 2016.